RJ Fulton, The Motley Fool
3 min read
The S&P 500 (SNPINDEX:^GSPC) fell 0.24% to 7,323, slipping below its closely watched 200-day moving average. The Nasdaq Composite (NASDAQINDEX:^IXIC) bucked the broader trend, gaining 0.42% to 24,430, supported by strength in select technology and retail stocks. Meanwhile, the Dow Jones Industrial Average (DJINDICES:^DJI) fell 1.11% to 50,198 as mounting regulatory concerns triggered heavy selling across managed healthcare stocks.
Selling pressure extended beyond equities, with gold plunging 3.51% to $3,728.60. The 10-year Treasury yield eased by two basis points to 5.10% but remains near recent highs. Industrial and consumer discretionary stocks provided pockets of strength, gaining 0.62% and 0.39%, respectively, while communication services fell 0.81%. Despite encouraging corporate earnings, elevated valuations and an increasingly hawkish Federal Reserve continue to complicate Wall Street’s path toward recovery.
Today’s biggest moves
Healthcare stocks came under considerable pressure on Wednesday, with UnitedHealth Group (NYSE:UNH) tumbling 10.21% and Humana (NYSE:HUM) plummeting 13%. The sell-off followed a federal regulatory proposal to expand Medicare Advantage audits and recover improper payments dating back to 2018, potentially exposing insurers to substantial financial liabilities.
Meanwhile, The TJX Companies (NYSE:TJX) surged 8.05% after reporting stronger-than-expected comparable sales growth and raising its full-year guidance ahead of the holiday shopping season. Amazon (NASDAQ:AMZN) gained 3.82% as anticipation surrounding Anthropic’s initial public offering drew renewed attention to the value of Amazon’s multibillion-dollar investment in the artificial intelligence company.
What this means for investors
Perhaps the most consequential development on Wednesday came from the release of the Federal Reserve’s latest meeting minutes, which indicated that nearly all officials anticipate further interest rate hikes may be necessary to bring inflation under control. The increasingly hawkish outlook helped push the U.S. dollar to a 19-month high, creating another headwind for multinational companies whose overseas earnings become less valuable when converted back into dollars.
Meanwhile, the S&P 500’s decline below its 200-day moving average marks a notable deterioration in the market’s longer-term trend. Although a breach of this technical benchmark doesn’t necessarily signal a prolonged downturn, the market’s inability to sustain a rally despite strong corporate earnings suggests that elevated valuations and restrictive monetary policy are becoming increasingly difficult to overcome.